CS-3150

CS-3150 · Daiichi Sankyo Co., Ltd.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for CS-3150, covering 2018-12-21 to 2019-10-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment [Phase 2]